AAAAAA
Results:
1-20
|
Results: 20
Authors:
Magne, N
Marcy, PY
Chamorey, E
Guardiola, E
Pivot, X
Schneider, M
Demard, F
Bensadoun, RJ
Citation: N. Magne et al., Concomitant twice-a-day radiotherapy and chemotherapy in unresectable headand neck cancer patients: A long-term quality of life analysis, HEAD NECK, 23(8), 2001, pp. 678-682
Authors:
Magne, N
Pivot, X
Bensadoun, RJ
Guardiola, E
Poissonnet, G
Dassonville, O
Francoual, M
Formento, JL
Demard, F
Schneider, M
Milano, G
Citation: N. Magne et al., The relationship of epidermal growth factor receptor levels to the prognosis of unresectable pharyngeal cancer patients treated by chemo-radiotherapy, EUR J CANC, 37(17), 2001, pp. 2169-2177
Authors:
Pivot, X
Wadler, S
Kelly, C
Ruxer, R
Tortochaux, J
Stern, J
Belpomme, D
Humblet, Y
Domenge, C
Clendeninn, N
Johnston, A
Penning, C
Schneider, M
Citation: X. Pivot et al., Result of two randomized trials comparing nolatrexed (Thymitaq (TM)) versus methotrexate in patients with recurrent head and neck cancer, ANN ONCOL, 12(11), 2001, pp. 1595-1599
Authors:
Guardiola, E
Pivot, X
Tchicknavorian, X
Magne, N
Otto, J
Thyss, A
Schneider, M
Citation: E. Guardiola et al., Combination of cisplatin-doxorubicin-cyclophosphamide in adenocarcinoma ofunknown primary site - A phase II trial, AM J CL ONC, 24(4), 2001, pp. 372-375
Authors:
Magne, N
Porsin, B
Pivot, X
Tchiknavorian, X
Marcy, PY
Foa, C
Otto, J
Schneider, M
Thyss, A
Citation: N. Magne et al., Primary lung sarcomas: long survivors obtained with iterative complete surgery, LUNG CANC, 31(2-3), 2001, pp. 241-245
Authors:
Pivot, X
Niyikiza, C
Poissonnet, G
Dassonville, O
Bensadoun, RJ
Guardiola, E
Benezery, CF
Demard, F
Schneider, A
Schneider, M
Citation: X. Pivot et al., Clinical prognostic factors for patients with recurrent head and neck cancer: Implications for randomized trials, ONCOL-BASEL, 61(3), 2001, pp. 197-204
Authors:
Pivot, X
Cals, L
Cupissol, D
Guardiola, E
Tchiknavorian, X
Guerrier, P
Merad, L
Wendling, JL
Barnouin, L
Savary, J
Thyss, A
Schneider, M
Citation: X. Pivot et al., Phase II trial of a paclitaxel-carboplatin combination in recurrent squamous cell carcinoma of the head and neck, ONCOL-BASEL, 60(1), 2001, pp. 66-71
Authors:
Pivot, X
Raymond, E
Laguerre, B
Degardin, M
Cals, L
Armand, JP
Lefebvre, JL
Gedouin, D
Ripoche, V
Kayitalire, L
Niyikiza, C
Johnson, R
Latz, J
Schneider, M
Citation: X. Pivot et al., Pemetrexed disodium in recurrent locally advanced or metastatic squamous cell carcinoma of the head and neck, BR J CANC, 85(5), 2001, pp. 649-655
Authors:
Pivot, X
Marghali, N
Etienne, MC
Bensadoun, RJ
Thyss, A
Otto, J
Francois, E
Renee, N
Lagrange, JL
Schneider, M
Milano, G
Citation: X. Pivot et al., A multivariate analysis for predicting cisplatin-induced delayed emesis, ONCOL REP, 7(3), 2000, pp. 515-519
Authors:
Pivot, X
Guardiola, E
Etienne, MC
Thyss, A
Foa, C
Otto, J
Schneider, M
Magne, N
Bensadoun, RJ
Renee, N
Milano, G
Citation: X. Pivot et al., An analysis of potential factors allowing an individual prediction of cisplatin-induced anaemia, EUR J CANC, 36(7), 2000, pp. 852-857
Authors:
Chatelut, E
Pivot, X
Otto, J
Chevreau, C
Thyss, A
Renee, N
Milano, G
Canal, P
Citation: E. Chatelut et al., A limited sampling strategy for determining carboplatin AUC and monitoringdrug dosage, EUR J CANC, 36(2), 2000, pp. 264-269
Authors:
Magne, N
Foa, C
Pivot, X
Thyss, A
Citation: N. Magne et al., Breast cancer in male-female dizygotous twins, PRESSE MED, 29(7), 2000, pp. 368-368
Authors:
Foa, C
Magne, N
Francois, E
Peroux, JL
Pivot, X
Thyss, A
Citation: C. Foa et al., Duodenal Burkitt lymphoma in a HIV-negative patient: a medical emergency, GASTRO CL B, 24(4), 2000, pp. 470-471
Authors:
Pivot, X
Asmar, L
Hortobagyi, GN
Theriault, R
Pastorini, F
Buzdar, A
Citation: X. Pivot et al., A retrospective study of first indicators of breast cancer recurrence, ONCOL-BASEL, 58(3), 2000, pp. 185-190
Authors:
Poissonnet, G
Dassonville, O
Pivot, X
Demard, F
Citation: G. Poissonnet et al., Cancers of the larynx and hypopharynx: Anatomy, anatompathology, clinical signs, TNM classification, treatment, B CANCER, 2000, pp. 27-38
Authors:
Pivot, X
Asmar, L
Buzdar, AU
Valero, V
Hortobagyi, G
Citation: X. Pivot et al., A unified definition of clinical anthracycline resistance breast cancer, BR J CANC, 82(3), 2000, pp. 529-534
Authors:
Tchiknavorian, X
Otto, J
Pivot, X
Arnaud, MC
Schneider, M
Thyss, A
Citation: X. Tchiknavorian et al., Splenic lymphoma with villous lymphocytes: dissociated response with Fludarabin, HEM CELL TH, 41(5), 1999, pp. 233-234
Authors:
Pivot, X
Asmar, L
Hortobagyi, GN
Citation: X. Pivot et al., The efficacy of chemotherapy with docetaxel and paclitaxel in anthracycline-resistant breast cancer (Review), INT J ONCOL, 15(2), 1999, pp. 381-386
Authors:
Etienne, MC
Pivot, X
Formento, JL
Bensadoun, RJ
Formento, P
Dassonville, O
Francoual, M
Poissonnet, G
Fontana, X
Schneider, M
Demard, F
Milano, G
Citation: Mc. Etienne et al., A multifactorial approach including tumoural epidermal growth factor receptor, p53, thymidylate synthase and dihydropyrimidine dehydrogenase to predict treatment outcome in head and neck cancer patients receiving 5-fluorouracil, BR J CANC, 79(11-12), 1999, pp. 1864-1869
Authors:
Llombart-Cussac, A
Pivot, X
Contesso, G
Rhor-Alvarado, A
Delord, JP
Spielmann, M
Tursz, T
Le Cesne, A
Citation: A. Llombart-cussac et al., Adjuvant chemotherapy for primary cardiac sarcomas: the IGR experience, BR J CANC, 78(12), 1998, pp. 1624-1628
Risultati:
1-20
|